NLTX stock pitch - 2023-04-10

Added to YB: 2023-04-10

Pitch date: 2023-04-10

Neoleukin Therapeutics, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

As of December 18, 2023, Neoleukin Therapeutics, Inc. was acquired by Neurogene Inc., in a reverse merger transaction.

Market Cap

$32.8M

Pitch Price

$14.60

Price Target

N/A

Dividend

N/A

EV/EBITDA

1.22

P/E

-1.14

EV/Sales

N/A

Sector

Biotechnology

A summary for this pitch has not been created yet.